Skip to main content
. 2016 Jul 6;7(38):62676–62686. doi: 10.18632/oncotarget.10445

Table 5. Prognostic model of DFS according to the survivin overexpression.

Prognostic group survivin n HR 95% CI P
Group 1 No (reference) 60
Group 2 Nuclear or Cytoplasmic 49 3.41 1.45-5.17 0.004
Group 3 Both 7 5.25 1.63-13.12 0.02

The Cox proportional hazard model was used to determine the hazard ratio (HR) between groups respecting to DFS, and the results were adjusted with pathologic node stage and type of surgery which showed prognostic significance of DFS in multivariate analysis.